Comparing the Efficacy of Two Valved Holding Chambers in Acute Wheezing

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2028

Conditions
Bronchitis ObstructiveBronchiolitis; ObstructionBronchospasm; Bronchitis
Interventions
DEVICE

VHC 1

Salbutamol 0.6-0.8 mg given 20-40 min. maximum four times depending on the bronchodilator response delivered via valved holding chamber 1. Same salbutamol dosing protocol for both arms. Only difference is the VHC used.

DEVICE

VHC 2

Salbutamol 0.6-0.8 mg given 20-40 min. maximum four times depending on the bronchodilator response delivered via valved holding chamber 2. Same salbutamol dosing protocol for both arms. Only difference is the VHC used.

Trial Locations (4)

33100

RECRUITING

Terveystalo Tampere, Tampere

33521

RECRUITING

Tampere University Hospital, Tampere

70210

RECRUITING

Kuopio University Hospital, Kuopio

90220

SUSPENDED

Oulu University Hospital, Oulu

All Listed Sponsors
collaborator

Kuopio University Hospital

OTHER

collaborator

Oulu University Hospital

OTHER

collaborator

Tampere University Hospital

OTHER

collaborator

Terveystalo Healthcare Services

UNKNOWN

lead

Tampere University

OTHER